Blueprint Medicines (NASDAQ:BPMC) Trading Up 9.7%

Shares of Blueprint Medicines Co. (NASDAQ:BPMC – Get Rating) were up 9.7% on Thursday . The company traded as high as $57.79 and last traded at $56.93. Approximately 369,365 shares changed hands during trading, a decline of 33% from the average daily volume of 548,409 shares. The stock had previously closed at $51.88. Wall Street […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Chris Varma ,Christina Rossi ,Raymond James ,Jeffreyw Albers ,Nicholasb Lydon ,Brian Druker ,Blueprint Medicines Corp ,Blueprint Medicines Co ,Morgan Stanley ,Nisa Investment Advisors ,Associates Corp ,Lazard Asset Management ,Nasdaq ,Affinity Asset Advisors ,Securities Exchange Commission ,Blueprint Medicines ,Get Rating ,Exchange Commission ,Director Jeffrey ,Asset Management ,Investment Advisors ,Alexis Borisy ,Blueprint Medicines Daily ,Nasdaq Bpmc ,Bpmc ,Medical ,Stocks ,Technicals ,